Прегледање према Аутор Goločorbin-Kon, Svetlana


Или, изаберите писмо испод како бисте прегледали презиме
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Приказивање резултата 45 do 64 od 68 < претходна   следећа >
Датум издавањаНасловАутор(и)
2019New pharmaceutical formulations and new indications for an old drug - methotrexateSvetlana Goločorbin-Kon ; Nebojša Pavlović ; Saša Vukmirović ; Maja Đanić ; Boris Milijašević ; Milica Paut Kusturica ; Ana Tomas Petrović ; Bojan Stanimirov ; Hani Al-Salami; Momir Mikov 
2018Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostatNebojša Pavlović ; Karmen Stankov ; Svetlana Goločorbin-Kon ; Mladena Lalić-Popović ; Bojan Stanimirov ; Maja Đanić ; Momir Mikov 
28-јул-2014Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A characterization studyMooranian A.; Negrulj R.; Chen-Tan N.; Al-Sallami H.; Fang Z.; Mukkur T.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Arfuso F.; Al-Salami H.
1-јан-2015Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro studyMooranian A.; Negrulj R.; Momir Mikov ; Svetlana Goločorbin-Kon ; Arfuso F.; Al-Salami H.
18-сеп-2018Novel nano-encapsulation of probucol in microgels: Scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analysesArmin Mooranian; Nassim Zamani; Mikov, Momir ; Goločorbin-Kon, Svetlana ; Stojanović, Goran ; Frank Arfuso; Hani Al-Salami
12-нов-2018Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analysesArmin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Hani Al-Salami
18-јул-2016On the optimal high dose methotrexate administration in the consolidation phase of acute lymphoblastic leukaemia in childrenDragan Spasić ; Nenad Grahovac ; Miodrag Žigić ; Jovanka Kolarović ; Svetlana Goločorbin-Kon ; Momir Mikov 
1-јан-2018Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndromeMaja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov 
12-нов-2018Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetesMooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H.
5-јун-2020Pharmacological Effects of Secondary Bile Acid Microparticles in Diabetic Murine ModelArmin Mooranian; Nassim Zamani; Božica Kovačević; Corina Mihaela Ionescu; Giuseppe Luna; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Sanja Kojić ; Hani Al-Salami
1-јун-2018Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and ProbioticsMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami
17-сеп-2019Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvantsKecman, S; Škrbić R.; Alma Badnjević Čengić; Armin Mooranian; Hani Al-Salami; Momir Mikov ; Svetlana Goločorbin-Kon 
1-јан-2014Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 DiabetesMooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Watts G.; Matthews V.; Arfuso F.; Lambros A.; Al-Salami H.
1-јан-2019Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic miceMooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H.
1-јан-2015Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatmentMooranian A.; Negrulj R.; Al-Sallami H.; Fang Z.; Momir Mikov ; Svetlana Goločorbin-Kon ; Fakhoury M.; Aruso F.; Al-Salami H.
20-сеп-2016Retention data of bile acids and their oxo derivatives in characterization of pharmacokinetic properties and in silico ADME modelingJovana Trifunović; Vladan Borčić; Saša Vukmirović ; Svetlana Goločorbin-Kon ; Momir Mikov 
1-дец-2017The Role of Drug Metabolites in the Inhibition of Cytochrome P450 EnzymesMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami
7-дец-2019A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compoundsArmin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević; Hani Al-Salami
2019Semisynthetic bile acids: a new therapeutic option for metabolic syndromeLazarević, Slavica; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Al-Salami, Hani; Mikov, Momir 
1-феб-2019Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatmentMooranian A.; Zamani N.; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Arfuso F.; Al-Salami H.
Приказивање резултата 45 do 64 od 68 < претходна   следећа >